Center for Biologics Evaluation and Research has chosen mRNA-3705 as one of four investigational medicines for accelerated development to address unmet medical needs for rare diseases
1,200+ developers will be selected to compete for $100,000+ investment and prizes to help develop responsible AI and LLMs